CN Stock MarketDetailed Quotes

000623 Jilin Aodong Pharmaceutical Group

Watchlist
  • 18.31
  • -0.58-3.07%
Market Closed Nov 15 15:00 CST
21.90BMarket Cap15.31P/E (TTM)

Jilin Aodong Pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-18.88%1.91B
-10.82%1.41B
9.35%861.34M
20.25%3.45B
23.05%2.35B
26.62%1.58B
23.64%787.66M
24.50%2.87B
19.67%1.91B
15.47%1.25B
Operating revenue
-18.88%1.91B
-10.82%1.41B
9.35%861.34M
20.25%3.45B
23.05%2.35B
26.62%1.58B
23.64%787.66M
24.50%2.87B
19.67%1.91B
15.47%1.25B
Other operating revenue
----
530.79%62.21M
----
153.85%45.58M
----
20.29%9.86M
----
-56.27%17.95M
----
-56.39%8.2M
Total operating cost
-9.75%2.01B
-2.69%1.45B
17.18%834.14M
21.11%3.39B
22.72%2.23B
25.83%1.49B
20.93%711.84M
18.96%2.8B
13.97%1.81B
11.14%1.19B
Operating cost
-0.39%1.16B
11.01%878.9M
28.06%529.18M
25.01%1.75B
22.60%1.17B
24.08%791.72M
38.49%413.24M
27.50%1.4B
25.53%951.85M
28.11%638.04M
Operating tax surcharges
-22.58%26.63M
-18.01%18.54M
-1.76%11.27M
8.58%46.43M
9.97%34.4M
7.28%22.62M
10.50%11.48M
8.82%42.77M
11.31%31.28M
11.96%21.08M
Operating expense
-28.09%495.6M
-27.18%337.19M
-8.48%173.75M
18.35%1.02B
29.66%689.21M
38.02%463.05M
1.81%189.84M
8.11%862.14M
-1.56%531.57M
-10.83%335.51M
Administration expense
8.95%208.39M
6.34%133.64M
10.28%66.51M
4.49%333.34M
3.93%191.27M
1.96%125.68M
2.67%60.31M
8.02%319.01M
3.30%184.04M
4.55%123.26M
Financial expense
-28.88%60.29M
-14.85%44.99M
44.17%34.5M
28.38%113.3M
23.21%84.77M
16.71%52.83M
-0.27%23.93M
21.80%88.25M
29.61%68.8M
42.08%45.27M
-Interest expense (Financial expense)
-28.68%77.08M
-13.31%58.93M
42.36%44.14M
0.95%144.35M
0.27%108.08M
-4.12%67.98M
-9.17%31M
9.58%142.99M
5.60%107.79M
5.00%70.9M
-Interest Income (Financial expense)
22.97%-18.54M
0.47%-15.66M
-50.32%-11.31M
44.63%-32.93M
44.23%-24.07M
45.62%-15.74M
27.25%-7.53M
4.33%-59.48M
16.90%-43.17M
25.06%-28.94M
Research and development
-6.38%55.81M
6.50%39.31M
45.22%18.94M
45.87%124.98M
27.97%59.62M
58.88%36.91M
22.26%13.04M
73.38%85.68M
36.12%46.59M
-5.40%23.23M
Credit Impairment Loss
70.03%-10.99M
63.97%-11.43M
-21.41%-16.32M
-41.45%-25.64M
-47.32%-36.67M
-68.37%-31.74M
-11.22%-13.44M
-109.77%-18.12M
-76.98%-24.89M
-15.23%-18.85M
Asset Impairment Loss
----
----
----
-20.07%-19.55M
----
----
----
-12.71%-16.28M
---424.06K
----
Other net revenue
10.45%1.32B
-52.60%477.14M
-86.41%59.93M
25.25%1.32B
282.41%1.2B
191.97%1.01B
1,106.21%440.92M
-41.74%1.06B
-82.12%312.89M
-63.05%344.77M
Fair value change income
-944.95%-23.23M
-842.59%-408.23M
-715.42%-202.65M
82.45%-111.06M
100.38%2.75M
112.26%54.97M
111.53%32.93M
-143.77%-632.66M
-725.44%-718.81M
-191.46%-448.55M
Invest income
14.64%1.31B
-4.48%864.57M
-34.44%267.15M
-17.63%1.35B
13.19%1.14B
16.26%905.16M
70.34%407.5M
-18.43%1.64B
-36.99%1.01B
-27.85%778.59M
-Including: Investment income associates
16.12%1.22B
-6.92%782.48M
-34.94%263.06M
-14.17%1.24B
12.43%1.05B
11.83%840.68M
74.20%404.3M
-26.09%1.44B
-40.07%932.4M
-29.06%751.78M
Asset deal income
-101.29%-468.6K
-100.72%-265.93K
64.62%-90.41K
1,044.55%36.16M
926.40%36.38M
830.93%36.77M
-147.09%-255.54K
435.92%3.16M
661.47%3.54M
1,626.98%3.95M
Other revenue
-10.91%44.35M
-21.63%32.49M
-16.62%11.83M
14.09%94.19M
17.11%49.79M
39.89%41.46M
-3.62%14.19M
-7.23%82.56M
-6.29%42.51M
21.77%29.64M
Operating profit
-7.72%1.22B
-60.22%436.3M
-83.14%87.12M
22.80%1.38B
221.71%1.32B
168.43%1.1B
11,168.10%516.74M
-36.19%1.13B
-76.57%411.58M
-56.91%408.61M
Add:Non operating Income
691.51%34.27M
383.54%19.75M
343.62%16.1M
-79.92%123.37M
-98.81%4.33M
-56.24%4.08M
147.37%3.63M
11,329.34%614.38M
13,078.33%363.47M
295.36%9.33M
Less:Non operating expense
148.61%2.52M
213.96%2.33M
-4.12%427.9K
-70.94%5.59M
-89.87%1.01M
-90.81%742.5K
-83.46%446.3K
609.93%19.23M
549.96%10M
851.55%8.08M
Total profit
-5.56%1.25B
-58.76%453.71M
-80.23%102.8M
-12.82%1.5B
73.50%1.33B
168.42%1.1B
15,394.08%519.93M
-2.59%1.72B
-56.48%765.06M
-56.85%409.86M
Less:Income tax cost
-38.92%35.04M
-239.13%-64.41M
-201.29%-29.85M
169.65%55.83M
147.01%57.37M
157.64%46.29M
157.09%29.47M
-1,813.74%-80.16M
-267.71%-122.04M
-1,036.50%-80.31M
Net profit
-4.05%1.22B
-50.84%518.12M
-72.95%132.65M
-19.80%1.44B
43.17%1.27B
115.00%1.05B
792.00%490.45M
1.70%1.8B
-47.35%887.09M
-48.77%490.17M
Net profit from continuing operation
-4.05%1.22B
-50.84%518.12M
-72.95%132.65M
-19.80%1.44B
43.17%1.27B
115.00%1.05B
792.00%490.45M
1.70%1.8B
-47.35%887.09M
-48.77%490.17M
Less:Minority Profit
-501.84%-25.57M
-107.97%-19.34M
-335.50%-11.01M
-176.90%-15.54M
-164.36%-4.25M
-108.13%-9.3M
208.41%4.68M
309.56%20.2M
187.40%6.6M
17.74%-4.47M
Net profit of parent company owners
-2.37%1.24B
-49.45%537.46M
-70.43%143.67M
-18.02%1.46B
44.72%1.27B
114.94%1.06B
719.23%485.78M
0.02%1.78B
-47.98%880.49M
-48.60%494.64M
Earning per share
Basic earning per share
-6.13%1.0614
-50.90%0.4632
-70.38%0.1277
-17.35%1.2971
46.01%1.1307
117.12%0.9434
727.45%0.4311
0.44%1.5694
-47.86%0.7744
-48.52%0.4345
Diluted earning per share
0.21%1.0614
-46.79%0.4632
-68.11%0.1277
-16.35%1.2272
41.49%1.0592
100.35%0.8705
668.52%0.4004
-2.93%1.467
-47.16%0.7486
-46.46%0.4345
Other composite income
111.84%238.88M
102.93%302.3M
631.74%141.28M
270.60%125.24M
116.74%112.77M
1,923.13%148.97M
130.90%19.31M
-289.51%-73.42M
272.06%52.03M
85.37%-8.17M
Other composite income of parent company owners
111.84%238.88M
102.93%302.3M
631.74%141.28M
270.60%125.24M
116.74%112.77M
1,923.13%148.97M
130.90%19.31M
-289.51%-73.42M
272.06%52.03M
85.37%-8.17M
Total composite income
5.40%1.46B
-31.79%820.42M
-46.26%273.94M
-9.15%1.57B
47.24%1.38B
149.55%1.2B
6,893.03%509.76M
-4.53%1.73B
-43.25%939.12M
-46.50%482M
Total composite income of parent company owners
6.92%1.48B
-30.72%839.76M
-43.58%284.95M
-7.16%1.59B
48.74%1.39B
149.17%1.21B
15,928.79%505.09M
-6.15%1.71B
-43.90%932.52M
-46.33%486.47M
Total composite income of minority owners
-501.84%-25.57M
-107.97%-19.34M
-335.50%-11.01M
-176.90%-15.54M
-164.36%-4.25M
-108.13%-9.3M
208.41%4.68M
309.56%20.2M
187.40%6.6M
17.74%-4.47M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhongzhun Certified Public Accountants (Special General Partnership)
--
--
--
Zhongzhun Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -18.88%1.91B-10.82%1.41B9.35%861.34M20.25%3.45B23.05%2.35B26.62%1.58B23.64%787.66M24.50%2.87B19.67%1.91B15.47%1.25B
Operating revenue -18.88%1.91B-10.82%1.41B9.35%861.34M20.25%3.45B23.05%2.35B26.62%1.58B23.64%787.66M24.50%2.87B19.67%1.91B15.47%1.25B
Other operating revenue ----530.79%62.21M----153.85%45.58M----20.29%9.86M-----56.27%17.95M-----56.39%8.2M
Total operating cost -9.75%2.01B-2.69%1.45B17.18%834.14M21.11%3.39B22.72%2.23B25.83%1.49B20.93%711.84M18.96%2.8B13.97%1.81B11.14%1.19B
Operating cost -0.39%1.16B11.01%878.9M28.06%529.18M25.01%1.75B22.60%1.17B24.08%791.72M38.49%413.24M27.50%1.4B25.53%951.85M28.11%638.04M
Operating tax surcharges -22.58%26.63M-18.01%18.54M-1.76%11.27M8.58%46.43M9.97%34.4M7.28%22.62M10.50%11.48M8.82%42.77M11.31%31.28M11.96%21.08M
Operating expense -28.09%495.6M-27.18%337.19M-8.48%173.75M18.35%1.02B29.66%689.21M38.02%463.05M1.81%189.84M8.11%862.14M-1.56%531.57M-10.83%335.51M
Administration expense 8.95%208.39M6.34%133.64M10.28%66.51M4.49%333.34M3.93%191.27M1.96%125.68M2.67%60.31M8.02%319.01M3.30%184.04M4.55%123.26M
Financial expense -28.88%60.29M-14.85%44.99M44.17%34.5M28.38%113.3M23.21%84.77M16.71%52.83M-0.27%23.93M21.80%88.25M29.61%68.8M42.08%45.27M
-Interest expense (Financial expense) -28.68%77.08M-13.31%58.93M42.36%44.14M0.95%144.35M0.27%108.08M-4.12%67.98M-9.17%31M9.58%142.99M5.60%107.79M5.00%70.9M
-Interest Income (Financial expense) 22.97%-18.54M0.47%-15.66M-50.32%-11.31M44.63%-32.93M44.23%-24.07M45.62%-15.74M27.25%-7.53M4.33%-59.48M16.90%-43.17M25.06%-28.94M
Research and development -6.38%55.81M6.50%39.31M45.22%18.94M45.87%124.98M27.97%59.62M58.88%36.91M22.26%13.04M73.38%85.68M36.12%46.59M-5.40%23.23M
Credit Impairment Loss 70.03%-10.99M63.97%-11.43M-21.41%-16.32M-41.45%-25.64M-47.32%-36.67M-68.37%-31.74M-11.22%-13.44M-109.77%-18.12M-76.98%-24.89M-15.23%-18.85M
Asset Impairment Loss -------------20.07%-19.55M-------------12.71%-16.28M---424.06K----
Other net revenue 10.45%1.32B-52.60%477.14M-86.41%59.93M25.25%1.32B282.41%1.2B191.97%1.01B1,106.21%440.92M-41.74%1.06B-82.12%312.89M-63.05%344.77M
Fair value change income -944.95%-23.23M-842.59%-408.23M-715.42%-202.65M82.45%-111.06M100.38%2.75M112.26%54.97M111.53%32.93M-143.77%-632.66M-725.44%-718.81M-191.46%-448.55M
Invest income 14.64%1.31B-4.48%864.57M-34.44%267.15M-17.63%1.35B13.19%1.14B16.26%905.16M70.34%407.5M-18.43%1.64B-36.99%1.01B-27.85%778.59M
-Including: Investment income associates 16.12%1.22B-6.92%782.48M-34.94%263.06M-14.17%1.24B12.43%1.05B11.83%840.68M74.20%404.3M-26.09%1.44B-40.07%932.4M-29.06%751.78M
Asset deal income -101.29%-468.6K-100.72%-265.93K64.62%-90.41K1,044.55%36.16M926.40%36.38M830.93%36.77M-147.09%-255.54K435.92%3.16M661.47%3.54M1,626.98%3.95M
Other revenue -10.91%44.35M-21.63%32.49M-16.62%11.83M14.09%94.19M17.11%49.79M39.89%41.46M-3.62%14.19M-7.23%82.56M-6.29%42.51M21.77%29.64M
Operating profit -7.72%1.22B-60.22%436.3M-83.14%87.12M22.80%1.38B221.71%1.32B168.43%1.1B11,168.10%516.74M-36.19%1.13B-76.57%411.58M-56.91%408.61M
Add:Non operating Income 691.51%34.27M383.54%19.75M343.62%16.1M-79.92%123.37M-98.81%4.33M-56.24%4.08M147.37%3.63M11,329.34%614.38M13,078.33%363.47M295.36%9.33M
Less:Non operating expense 148.61%2.52M213.96%2.33M-4.12%427.9K-70.94%5.59M-89.87%1.01M-90.81%742.5K-83.46%446.3K609.93%19.23M549.96%10M851.55%8.08M
Total profit -5.56%1.25B-58.76%453.71M-80.23%102.8M-12.82%1.5B73.50%1.33B168.42%1.1B15,394.08%519.93M-2.59%1.72B-56.48%765.06M-56.85%409.86M
Less:Income tax cost -38.92%35.04M-239.13%-64.41M-201.29%-29.85M169.65%55.83M147.01%57.37M157.64%46.29M157.09%29.47M-1,813.74%-80.16M-267.71%-122.04M-1,036.50%-80.31M
Net profit -4.05%1.22B-50.84%518.12M-72.95%132.65M-19.80%1.44B43.17%1.27B115.00%1.05B792.00%490.45M1.70%1.8B-47.35%887.09M-48.77%490.17M
Net profit from continuing operation -4.05%1.22B-50.84%518.12M-72.95%132.65M-19.80%1.44B43.17%1.27B115.00%1.05B792.00%490.45M1.70%1.8B-47.35%887.09M-48.77%490.17M
Less:Minority Profit -501.84%-25.57M-107.97%-19.34M-335.50%-11.01M-176.90%-15.54M-164.36%-4.25M-108.13%-9.3M208.41%4.68M309.56%20.2M187.40%6.6M17.74%-4.47M
Net profit of parent company owners -2.37%1.24B-49.45%537.46M-70.43%143.67M-18.02%1.46B44.72%1.27B114.94%1.06B719.23%485.78M0.02%1.78B-47.98%880.49M-48.60%494.64M
Earning per share
Basic earning per share -6.13%1.0614-50.90%0.4632-70.38%0.1277-17.35%1.297146.01%1.1307117.12%0.9434727.45%0.43110.44%1.5694-47.86%0.7744-48.52%0.4345
Diluted earning per share 0.21%1.0614-46.79%0.4632-68.11%0.1277-16.35%1.227241.49%1.0592100.35%0.8705668.52%0.4004-2.93%1.467-47.16%0.7486-46.46%0.4345
Other composite income 111.84%238.88M102.93%302.3M631.74%141.28M270.60%125.24M116.74%112.77M1,923.13%148.97M130.90%19.31M-289.51%-73.42M272.06%52.03M85.37%-8.17M
Other composite income of parent company owners 111.84%238.88M102.93%302.3M631.74%141.28M270.60%125.24M116.74%112.77M1,923.13%148.97M130.90%19.31M-289.51%-73.42M272.06%52.03M85.37%-8.17M
Total composite income 5.40%1.46B-31.79%820.42M-46.26%273.94M-9.15%1.57B47.24%1.38B149.55%1.2B6,893.03%509.76M-4.53%1.73B-43.25%939.12M-46.50%482M
Total composite income of parent company owners 6.92%1.48B-30.72%839.76M-43.58%284.95M-7.16%1.59B48.74%1.39B149.17%1.21B15,928.79%505.09M-6.15%1.71B-43.90%932.52M-46.33%486.47M
Total composite income of minority owners -501.84%-25.57M-107.97%-19.34M-335.50%-11.01M-176.90%-15.54M-164.36%-4.25M-108.13%-9.3M208.41%4.68M309.56%20.2M187.40%6.6M17.74%-4.47M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhongzhun Certified Public Accountants (Special General Partnership)------Zhongzhun Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data